Skip to main content
OpenTrials

Clinical trial condition

Hyperammonemia

Explore clinical trials studying Hyperammonemia. Study availability and eligibility vary by location and protocol.

20 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hyperammonemia trial results

Completed

Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)

NCT00947297

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • Long Beach Memorial Long Beach, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

NCT00992459

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • Long Beach Memorial Long Beach, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Denver Children's Hospital Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders

NCT02246218

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • Kaiser Permanente Regional Metabolic Center Los Angeles, California, United States
  • Stanford Center for Clinical & Translational Research & Education Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Shands at University of Florida Gainesville, Florida, United States
View all 17 locations
View Trial Details
Completed

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

NCT01966419

Conditions
Acute Episode of Overt Hepatic Encephalopathy, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • Phoenix, Arizona, United States
  • Phoenix, Arizona, United States
  • Little Rock, Arkansas, United States
  • Coronado, California, United States
View all 131 locations
View Trial Details
Completed

Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia

NCT01599286

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +21 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States
  • The Children's Hospital of Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Completed

Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants

NCT01624311

Conditions
Amino Acid Metabolism, Inborn Errors, Argininosuccinic Aciduria, Brain Diseases, +31 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Columbia University, Morgan Stanley Children's Hospital New York, United States
  • Medical College Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Anaplerotic Therapy in Propionic Acidemia

NCT00645879

Conditions
Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more
Locations
  • University of Utah, Department of Pediatrics Salt Lake City, Utah, United States
View Trial Details

Related conditions